Company: THC
Filing Date: 2025-04-11
Form Type: DEF 14A
Source: 0001193125-25-079143
Chunk: 34

Company: TENET HEALTHCARE CORP
Filing Date: 2025-04-11
Form: DEF 14A
Chunk 34
---
 a description of our policies on ethics and conduct can be found above. In the event that Tenet or its subsidiaries is a participant in a transaction in which any director, executive officer, holder of more than 5% of our outstanding shares or any immediate family member of any of these persons has a direct or indirect material interest, our written policy is to require that any such transaction be reviewed and approved by the Governance Committee, which is composed entirely of independent directors. There were no “related person” transactions that require disclosure under the SEC rules since the beginning of our last completed fiscal year.

| 2025 PROXY STATEMENT |     | 37 |

Corporate Governance and Board Practices Communications with the Board of Directors by Shareholders and Other Interested Parties Shareholders and interested parties may communicate with the Board of Directors, including our Chairman, by email to boardofdirectors@tenethealth.comor by writing to the Board in care of the Corporate Secretary, Tenet Healthcare Corporation, 14201 Dallas Parkway, Dallas, Texas 75254. Shareholder communications will be reviewed internally to determine if the shareholder’s concern can best be addressed by referral to a Tenet department, such as Investor Relations. All other communications will be referred to the Corporate Secretary, who will determine if the communication should be brought to the attention of the full Board, the Chairman of the Board or a particular Board committee or Board member. Other interested parties may make their concerns known to our non-employeedirectors by following the procedures for reporting concerns to the Audit Committee set forth in our Corporate Governance Principles, which are available under the “Governance” heading in the Investors section on our website at www.tenethealth.com*.

| 38 |

Director Compensation The HR Committee reviews our non-employeedirector compensation programs each year with the assistance of the HR Committee’s independent compensation consultant. The Board considers any changes recommended by the HR Committee following its review. Following this review in May 2024, the Board increased the annual cash retainer paid to non-employeedirectors from $100,000 to $125,000. Employee directors do not receive any compensation for their service as a director. All 2024 compensation for our Chairman and Chief Executive Officer, Dr. Sutaria, is shown in the 2024 Summary Compensation Table on page 62. Our 2024 annual compensation program for non-employeedirectors was structured as follows:

| Annual Compensation Element                               |     | Amount |         |
|:----------------------------------------------------------|:----|